GILT accelerates autoimmunity to the melanoma antigen tyrosinase-related protein 1

Journal of Immunology

Volumn 185, Issue 5, 2010, Pages 2828-2835

  Rausch, Matthew P ^a,b   Irvine, Kari R ^c   Antony, Paul A ^c,e   Restifo, Nicholas P ^c   Cresswell, Peter ^d   Hastings, K Taraszka ^a,b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAMMA INTERFERON INDUCIBLE LYSOSOMAL THIOL REDUCTASE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MELANOMA ANTIGEN; TYROSINASE RELATED PROTEIN 1; UNCLASSIFIED DRUG; CANCER ANTIBODY; HLA ANTIGEN CLASS 2; IFI30 PROTEIN, MOUSE; MEMBRANE PROTEIN; OXIDOREDUCTASE; TUMOR ANTIGEN; TYRP1 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CANCER IMMUNOTHERAPY; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISULFIDE BOND; EFFECTOR CELL; IN VITRO STUDY; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; TRANSGENIC MOUSE; VITILIGO; ADOPTIVE TRANSFER; AMINO ACID SEQUENCE; ANIMAL; ANTIGEN PRESENTATION; AUTOIMMUNE DISEASE; BIOSYNTHESIS; C57BL MOUSE; ENZYMOLOGY; EXPERIMENTAL MELANOMA; GENETICS; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; MOUSE MUTANT; PHYSIOLOGY; SQUAMOUS CELL CARCINOMA; TRANSPLANTATION; TUMOR CELL LINE;

ADOPTIVE TRANSFER; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, NEOPLASM; ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; AUTOIMMUNE DISEASES; CARCINOMA, SQUAMOUS CELL; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; HISTOCOMPATIBILITY ANTIGENS CLASS II; MELANOMA, EXPERIMENTAL; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; OXIDOREDUCTASES; VITILIGO;

EID: 78049356430     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000945     Document Type: Article

References (50)

1. Arunachalam, B., U. T. Phan, H. J. Geuze, and P. Cresswell. 2000. Enzymatic reduction of disulfide bonds in lysosomes: characterization of a gammainterferon- inducible lysosomal thiol reductase (GILT). Proc. Natl. Acad. Sci. USA 97: 745-750.
2. Honey, K., M. Duff, C. Beers, W. H. Brissette, E. A. Elliott, C. Peters, M. Maric, P. Cresswell, and A. Rudensky. 2001. Cathepsin S regulates the expression of cathepsin L and the turnover of γ-interferon-inducible lysosomal thiol reductase in B lymphocytes. J. Biol. Chem. 276: 22573-22578.
3. Lackman, R. L., A. M. Jamieson, J. M. Griffith, H. Geuze, and P. Cresswell. 2007. Innate immune recognition triggers secretion of lysosomal enzymes by macrophages. Traffic 8: 1179-1189.
4. Luster, A. D., R. L. Weinshank, R. Feinman, and J. V. Ravetch. 1988. Molecular and biochemical characterization of a novel γ-interferon- inducible protein. J. Biol. Chem. 263: 12036-12043.
5. Maric, M., B. Arunachalam, U. T. Phan, C. Dong, W. S. Garrett, K. S. Cannon, C. Alfonso, L. Karlsson, R. A. Flavell, and P. Cresswell. 2001. Defective antigen processing in GILT-free mice. Science 294: 1361-1365.
6. Haque, M. A., P. Li, S. K. Jackson, H. M. Zarour, J. W. Hawes, U. T. Phan, M. Maric, P. Cresswell, and J. S. Blum. 2002. Absence of γ-interferon-inducible lysosomal thiol reductase in melanomas disrupts T cell recognition of select immunodominant epitopes. J. Exp. Med. 195: 1267-1277.
7. Phan, U. T., B. Arunachalam, and P. Cresswell. 2000. Gamma-interferon- inducible lysosomal thiol reductase (GILT): maturation, activity, and mechanism of action. J. Biol. Chem. 275: 25907-25914.
8. Hastings, K. T., R. L. Lackman, and P. Cresswell. 2006. Functional requirements for the lysosomal thiol reductase GILT in MHC class II-restricted antigen processing. J. Immunol. 177: 8569-8577.
9. Sealy, R., W. Chaka, S. Surman, S. A. Brown, P. Cresswell, and J. L. Hurwitz. 2008. Target peptide sequence within infectious human immunodeficiency virus type 1 does not ensure envelope-specific T-helper cell reactivation: influences of cysteine protease and gamma interferon-induced thiol reductase activities. Clin. Vaccine Immunol. 15: 713-719.
10. + T cell responses. J. Immunol. 163: 5820-5826.
11. García-Borrón, J. C., and F. Solano. 2002. Molecular anatomy of tyrosinase and its related proteins: beyond the histidine-bound metal catalytic center. Pigment Cell Res. 15: 162-173.
12. Negroiu, G., R. A. Dwek, and S. M. Petrescu. 2000. Folding and maturation of tyrosinase-related protein-1 are regulated by the post-translational formation of disulfide bonds and by N-glycan processing. J. Biol. Chem. 275: 32200-32207.
13. Naughton, G. K., M. Eisinger, and J. C. Bystryn. 1983. Antibodies to normal human melanocytes in vitiligo. J. Exp. Med. 158: 246-251.
14. + T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/MART1. J. Invest. Dermatol. 116: 891-897.
15. Mandelcorn-Monson, R. L., N. H. Shear, E. Yau, S. Sambhara, B. H. Barber, D. Spaner, and M. A. DeBenedette. 2003. Cytotoxic T lymphocyte reactivity to gp100, MelanA/MART-1, and tyrosinase, in HLA-A2-positive vitiligo patients. J. Invest. Dermatol. 121: 550-556.
16. Ogg, G. S., P. Rod Dunbar, P. Romero, J. L. Chen, and V. Cerundolo. 1998. High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo. J. Exp. Med. 188: 1203-1208.
17. Palermo, B., R. Campanelli, S. Garbelli, S. Mantovani, E. Lantelme, V. Brazzelli, M. Ardigó, G. Borroni, M. Martinetti, C. Badulli, et al. 2001. Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo. J. Invest. Dermatol. 117: 326-332.
18. Muranski, P., A. Boni, P. A. Antony, L. Cassard, K. R. Irvine, A. Kaiser, C. M. Paulos, D. C. Palmer, C. E. Touloukian, K. Ptak, et al. 2008. Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood 112: 362-373.
19. Smyth, I. M., L.Wilming, A.W. Lee, M. S. Taylor, P. Gautier, K. Barlow, J.Wallis, S. Martin, R. Glithero, B. Phillimore, et al. 2006. Genomic anatomy of the Tyrp1 (brown) deletion complex. Proc. Natl. Acad. Sci. USA 103: 3704-3709.
20. + T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts. J. Exp. Med. 207: 637-650.
21. + T cells differentiated in vivo eradicate established melanoma. J. Exp. Med. 207: 651-667.
22. + T lymphocytes. Proc. Natl. Acad. Sci. USA 96: 2982-2987.
23. Gogas, H., J. Ioannovich, U. Dafni, C. Stavropoulou-Giokas, K. Frangia, D. Tsoutsos, P. Panagiotou, A. Polyzos, O. Papadopoulos, A. Stratigos, et al. 2006. Prognostic significance of autoimmunity during treatment of melanoma with interferon. N. Engl. J. Med. 354: 709-718.
24. Fusenig, N. E., S. M. Amer, P. Boukamp, and P. K. Worst. 1978. Characteristics of chemically transformed mouse epidermal cells in vitro and in vivo. Bull. Cancer 65: 271-279.
25. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176: 1693-1702.
26. Barjaktarević, I., A. Rahman, S. Radoja, B. Bogunović, A. Vollmer, S.Vukmanović, and M. Marić. 2006. Inhibitory role of IFN-gamma-inducible lysosomal thiol reductase in T cell activation. J. Immunol. 177: 4369-4375.
27. von Boehmer, H. 1990. Developmental biology of T cells in T cell-receptor transgenic mice. Annu. Rev. Immunol. 8: 531-556.
28. Borgulya, P., H. Kishi, Y. Uematsu, and H. von Boehmer. 1992. Exclusion and inclusion of alpha and beta T cell receptor alleles. Cell 69: 529-537.
29. McGargill, M. A., D. Mayerova, H. E. Stefanski, B. Koehn, E. A. Parke, S. C. Jameson, A. Panoskaltsis-Mortari, and K. A. Hogquist. 2002. A spontaneous CD8 T celldependent autoimmune disease to an antigen expressed under the human keratin 14 promoter. J. Immunol. 169: 2141-2147.
30. Robbins, P. F., M. El-Gamil, Y. F. Li, G. Zeng, M. Dudley, and S. A. Rosenberg. 2002. Multiple HLA class II-restricted melanocyte differentiation antigens are recognized by tumor-infiltrating lymphocytes from a patient with melanoma. J. Immunol. 169: 6036-6047.
31. + T-cell function. Cancer Res. 62: 5144-5147.
32. 2+ responses triggered in T cells by dendritic cells compared with B cells. J. Exp. Med. 188: 1473-1484.
33. Berson, J. F., D. C. Harper, D. Tenza, G. Raposo, and M. S. Marks. 2001. Pmel17 initiates premelanosome morphogenesis within multivesicular bodies. Mol. Biol. Cell 12: 3451-3464.
34. Kobayashi, H., T. Kokubo, K. Sato, S. Kimura, K. Asano, H. Takahashi, H. Iizuka, N. Miyokawa, and M. Katagiri. 1998. CD4+ T cells from peripheral blood of a melanoma patient recognize peptides derived from nonmutated tyrosinase. Cancer Res. 58: 296-301.
35. Parkhurst, M. R., J. P. Riley, P. F. Robbins, and S. A. Rosenberg. 2004. Induction of CD4+ Th1 lymphocytes that recognize known and novel class II MHC restricted epitopes from the melanoma antigen gp100 by stimulation with recombinant protein. J. Immunother. 27: 79-91.
36. Topalian, S.L., M.I. Gonzales, M. Parkhurst, Y.F. Li, S. Southwood, A. Sette, S.A. Rosenberg, and P.F. Robbins. 1996. Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes. J. Exp. Med. 183:1965-1971.
37. Touloukian, C. E., W. W. Leitner, S. L. Topalian, Y. F. Li, P. F. Robbins, S. A. Rosenberg, and N. P. Restifo. 2000. Identification of a MHC class IIrestricted human gp100 epitope using DR4-IE transgenic mice. J. Immunol. 164: 3535-3542.
38. Bogunovic, B., M. Stojakovic, L. Chen, and M. Maric. 2008. An unexpected functional link between lysosomal thiol reductase and mitochondrial manganese superoxide dismutase. J. Biol. Chem. 283: 8855-8862.
39. Maric, M., I. Barjaktarevic, B. Bogunovic, M. Stojakovic, C. Maric, and S. Vukmanovic. 2009. Cutting edge: developmental up-regulation of IFN-gamma-inducible lysosomal thiol reductase expression leads to reduced T cell sensitivity and less severe autoimmunity. J. Immunol. 182: 746-750.
40. Lambe, T., J. C. Leung, T. Bouriez-Jones, K. Silver, K. Makinen, T. L. Crockford, H. Ferry, J. V. Forrester, and R. J. Cornall. 2006. CD4 T cell-dependent autoimmunity against a melanocyte neoantigen induces spontaneous vitiligo and depends upon Fas-Fas ligand interactions. J. Immunol. 177: 3055-3062.
41. Nichols, L. A., Y. Chen, T. A. Colella, C. L. Bennett, B. E. Clausen, and V. H. Engelhard. 2007. Deletional self-tolerance to a melanocyte/melanoma antigen derived from tyrosinase is mediated by a radio-resistant cell in peripheral and mesenteric lymph nodes. J. Immunol. 179: 993-1003.
42. Gregg, R. K., L. Nichols, Y. Chen, B. Lu, and V. H. Engelhard. 2010. Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinasespecific TCR transgenic mice. J. Immunol. 184: 1909-1917.
43. Tsujisaki, M., M. Igarashi, K. Sakaguchi, M. Eisinger, M. Herlyn, and S. Ferrone. 1987. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes. J. Immunol. 138: 1310-1316.
44. Auböck, J., D. Niederwieser, N. Romani, P. Fritsch, and C. Huber. 1985. Human interferon-gamma induces expression of HLA-DR on keratinocytes and melanocytes. Arch. Dermatol. Res. 277: 270-275.
45. Hedley, S. J., R. Metcalfe, D. J. Gawkrodger, A. P. Weetman, and S. Mac Neil. 1998. Vitiligo melanocytes in long-term culture show normal constitutive and cytokine-induced expression of intercellular adhesion molecule-1 and major histocompatibility complex class I and class II molecules. Br. J. Dermatol. 139: 965-973.
46. Herlyn, M., D. Guerry, and H. Koprowski. 1985. Recombinant gamma-interferon induces changes in expression and shedding of antigens associated with normal human melanocytes, nevus cells, and primary and metastatic melanoma cells. J. Immunol. 134: 4226-4230.
47. Houghton, A. N., T. M. Thomson, D. Gross, H. F. Oettgen, and L. J. Old. 1984. Surface antigens of melanoma and melanocytes: specificity of induction of Ia antigens by human gamma-interferon. J. Exp. Med. 160: 255-269.
48. Le Poole, I. C., T. Mutis, R. M. van den Wijngaard, W. Westerhof, T. Ottenhoff, R. R. de Vries, and P. K. Das. 1993. A novel, antigen-presenting function of melanocytes and its possible relationship to hypopigmentary disorders. J. Immunol. 151: 7284-7292.
49. + cytotoxic T cells in association with histocompatibility leukocyte antigen DR11. J. Exp. Med. 189: 871-876.
50. + T cells. Proc. Natl. Acad. Sci. USA 97: 400-405.